NanoPlasmiRNA", a new European project supported by EuroNanoMed II , an ERA-NET granted for funding through the European Commission ’s 7th Framework Programme. The project has received €490,000 funding and it will run from January 2016 to December 2017.
Last week the Labion team was invovled in several initiative speaking about the research done by the group in the different area of Nanomedicine. Dr. Carlo Morasso gave a talk titled "Simultaneous Detection of Multiple Biomarkers by Means of Polymer Nanopillar – Gold Arrays" at NanotechItaly 2015 - Bologna (IT)+ Nanotechitaly is the most important event...Read more
Labion participates to the preparation of a special issue of Biomed. Res. Int. on the impact of nanotechnology on personalized treatments. A clear shift is occurring in medicine. Molecularly targeted therapies opened the era of "personalized medicine” which, in its simplest definition, consists in administering the right drug to the right patient at the right moment....Read more
A new article from Labion, recently published on ACS Nano, demonstrate how polymer nanopillar - gold arrays can be used for the ultrasensitive simultaneous detection of multiple genetic biomarkers by means of Surface Enhanced Raman Spectroscopy . This is an important step for the Read more